Royal Capital Wealth Management, LLC Pfizer Inc Transaction History

Royal Capital Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $73,807 - $86,273	-2,300 Reduced 25.63%	6,675 $221,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $13,183 - $15,253	-365 Reduced 3.91%	8,975 $329,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $3,939 - $5,128	-100 Reduced 1.06%	9,340 $381,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $24,943 - $30,449	-570 Reduced 5.69%	9,440 $413,000
Q2 2022 Aug 16, 2022	SELL	$46.53 - $55.17 $87,011 - $103,167	-1,870 Reduced 15.74%	10,010 $525,000
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $52,612 - $65,193	1,150 Added 10.72%	11,880 $615,000
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $443,363 - $657,212	10,730 New	10,730 $634,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Royal Capital Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Capital Wealth Management, LLC with notifications on news.